GridAI Technologies Corp. (GRDX): M&A transaction — GridAI completes rescission of ImmunogenX acquisition, removes $83.2M in assets

GridAI Technologies Corp.

Rescission completed Dec 31, 2025; Immuno LLC is no longer a subsidiary.
Pro forma total assets as of Sep 30, 2025: $52.2M (down from $135.4M).
Pro forma net loss from continuing ops for nine months ended Sep 30, 2025: $2.59M, diluted EPS -$1.77.
Removed 11,777,418 shares of Series G Preferred Stock issued to IMGX as part of rescission.
Pro forma net loss from continuing ops for year ended Dec 31, 2024: $15.62M, diluted EPS -$4.62.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

GridAI Technologies Corp. completed a disposition involving ImmunogenX, LLC and each of the individuals or entities who are the former shareholders of ImmunogenX, Inc. (closed 2025-12-31).

Action: disposition
Counterparty: ImmunogenX, LLC and each of the individuals or entities who are the former shareholders of ImmunogenX, Inc.
Closing: 2025-12-31

Exact text from the filing

On December 31, 2025, the Company, Immuno LLC and the Shareholders completed the transactions contemplated by the Rescission Agreement, as amended by the Rescission Agreement Amendment (the “Transaction”), including the transfer by the Coamny to the Shareholders of all of the issued and outstanding membership interests of Immuno LLC held by the Company.

View on SEC.gov

28 m&a transactions filed in the last 30 days. Browse all m&a transactions →

GridAI Technologies Corp. filing history →

Source: SEC EDGAR

accession 0001104659-26-001755

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.